PortfoliosLab logoPortfoliosLab logo
RXL vs. QULL
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

RXL vs. QULL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares Ultra Health Care (RXL) and ETRACS 2x Leveraged MSCI US Quality Factor TR ETN (QULL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, RXL achieves a 4.11% return, which is significantly lower than QULL's 17.09% return.


RXL

1D
1.01%
1M
14.82%
6M
3.71%
YTD
4.11%
1Y
42.43%
3Y*
5.91%
5Y*
2.43%
10Y*
12.45%
ALL TIME*
14.49%

QULL

1D
1.20%
1M
1.38%
6M
16.44%
YTD
17.09%
1Y
33.77%
3Y*
28.35%
5Y*
14.76%
10Y*
ALL TIME*
19.33%
*Multi-year figures are annualized to reflect compound growth (CAGR)

RXL vs. QULL - Yearly Performance Comparison


2026 (YTD)20252024202320222021
RXL
ProShares Ultra Health Care
4.11%19.76%-2.72%-3.15%-15.26%40.41%
QULL
ETRACS 2x Leveraged MSCI US Quality Factor TR ETN
17.09%17.61%38.03%57.07%-42.00%51.36%

Correlation

The correlation between RXL and QULL is 0.38, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.38

Correlation (3Y)
Calculated over the trailing 3-year period

0.51

Correlation (5Y)
Calculated over the trailing 5-year period

0.61

Correlation (All Time)
Calculated using the full available price history since Feb 5, 2021

0.62

Over the past year, the correlation between RXL and QULL has dropped to 0.38 - well below their long-term average of 0.62, suggesting their price drivers have been diverging.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

RXL vs. QULL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RXL
RXL Risk / Return Rank: 5050
Overall Rank
RXL Sharpe Ratio Rank: 5151
Sharpe Ratio Rank
RXL Sortino Ratio Rank: 5757
Sortino Ratio Rank
RXL Omega Ratio Rank: 4848
Omega Ratio Rank
RXL Calmar Ratio Rank: 5252
Calmar Ratio Rank
RXL Martin Ratio Rank: 3939
Martin Ratio Rank

QULL
QULL Risk / Return Rank: 5353
Overall Rank
QULL Sharpe Ratio Rank: 5353
Sharpe Ratio Rank
QULL Sortino Ratio Rank: 5353
Sortino Ratio Rank
QULL Omega Ratio Rank: 5050
Omega Ratio Rank
QULL Calmar Ratio Rank: 4848
Calmar Ratio Rank
QULL Martin Ratio Rank: 6262
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RXL vs. QULL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra Health Care (RXL) and ETRACS 2x Leveraged MSCI US Quality Factor TR ETN (QULL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


RXLQULLDifference
Sharpe ratioReturn per unit of total volatility

-0.03

Sortino ratioReturn per unit of downside risk

+0.12

Omega ratioGain probability vs. loss probability

1.23

1.24

-0.01

Calmar ratioReturn relative to maximum drawdown

2.00

1.84

+0.16

Martin ratioReturn relative to average drawdown

4.56

8.08

-3.51

RXL vs. QULL - Sharpe Ratio Comparison

The current RXL Sharpe Ratio is 1.34, which is comparable to the QULL Sharpe Ratio of 1.37. The chart below compares the historical Sharpe Ratios of RXL and QULL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

RXL vs. QULL - Drawdown Comparison

The maximum RXL drawdown since its inception was -67.70%, which is greater than QULL's maximum drawdown of -51.83%. Use the drawdown chart below to compare losses from any high point for RXL and QULL.


Loading charts...

Drawdown Indicators


RXLQULLDifference

Max Drawdown

Largest peak-to-trough decline

-67.70%

-51.83%

-15.87%

Max Drawdown (1Y)

Largest decline over 1 year

-21.33%

-18.43%

-2.90%

Max Drawdown (3Y)

Largest decline over 3 years

-36.08%

-36.82%

+0.74%

Max Drawdown (5Y)

Largest decline over 5 years

-36.08%

-51.83%

+15.75%

Max Drawdown (10Y)

Largest decline over 10 years

-51.00%

Current Drawdown

Current decline from peak

-5.43%

-2.08%

-3.35%

Average Drawdown

Average peak-to-trough decline

-15.80%

-13.76%

-2.04%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.32%

4.19%

+5.13%

Volatility

RXL vs. QULL - Volatility Comparison

ProShares Ultra Health Care (RXL) has a higher volatility of 12.40% compared to ETRACS 2x Leveraged MSCI US Quality Factor TR ETN (QULL) at 5.83%. This indicates that RXL's price experiences larger fluctuations and is considered to be riskier than QULL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


RXLQULLDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.40%

5.83%

+6.57%

Volatility (6M)

Calculated over the trailing 6-month period

23.85%

19.60%

+4.25%

Volatility (1Y)

Calculated over the trailing 1-year period

31.94%

24.80%

+7.14%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

30.19%

35.64%

-5.45%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

33.42%

34.89%

-1.47%

RXL vs. QULL - Expense Ratio Comparison

Both RXL and QULL have an expense ratio of 0.95%.


Dividends

RXL vs. QULL - Dividend Comparison

RXL's dividend yield for the trailing twelve months is around 1.32%, while QULL has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
QULL
ETRACS 2x Leveraged MSCI US Quality Factor TR ETN
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
RXL
ProShares Ultra Health Care
1.32%1.43%1.22%0.18%0.32%0.10%0.15%0.27%0.32%0.11%0.12%0.93%

Frequently Asked Questions


RXL and QULL have a correlation of 0.38, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

RXL has higher volatility (12.40%) compared to QULL (5.83%). In terms of maximum drawdown, RXL dropped -67.70% vs QULL's -51.83%.

On 5-year performance, QULL leads with 14.76% vs 2.43% for RXL. Both ETFs have the same 0.95% expense ratio. On volatility, QULL has been the lower-risk option at 5.83%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, QULL has performed better with a 14.76% return vs 2.43%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

RXL and QULL have the same expense ratio: 0.95% per year.

RXL has the higher dividend yield at 1.32%, compared with 0.00% for QULL.

RXL tracks Dow Jones U.S. Health Care Index (200%), while QULL tracks MSCI USA Sector Neutral Quality Index. They also come from different issuers: ProShares and UBS.

QULL currently has the higher Sharpe Ratio (1.37 vs 1.34), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for RXL and QULL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer